Liraglutide Reduces Carotid Intima-Media Thickness by Reducing Small Dense Low-Density Lipoproteins in a Real-World Setting of Patients with Type 2 Diabetes: A Novel Anti-Atherogenic Effect

Cardiovascular outcomes trials with incretin-based medications: a critical review of data available on GLP-1 receptor agonists and DPP-4 inhibitors

(2020) Alexandros Sachinidis et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Microvascular and macrovascular effects of liraglutide

(2019) Domenico Cianflone et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Exenatide once-weekly improves metabolic parameters, endothelial dysfunction and carotid intima-media thickness in patients with type-2 diabetes: An 8-month prospective study

(2019) Angelo Maria Patti et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Liraglutide in combination with metformin may improve the atherogenic lipid profile and decrease C-reactive protein level in statin treated obese patients with coronary artery disease and newly diagnosed type 2 diabetes: A randomized trial

(2019) Christian Anholm et al.   ATHEROSCLEROSIS

Cardiovascular effects of glucagon-like peptide 1 receptor agonists: from mechanistic studies in humans to clinical outcomes

(2019) Valerie D Heuvelman et al.   CARDIOVASCULAR RESEARCH

Cardiovascular disease risk factor responses to a type 2 diabetes care model including nutritional ketosis induced by sustained carbohydrate restriction at 1 year: an open label, non-randomized, controlled study

(2018) Nasir H. Bhanpuri et al.   Cardiovascular Diabetology

Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at 1 Year: An Open-Label, Non-Randomized, Controlled Study

(2018) Sarah J. Hallberg et al.   Diabetes Therapy

Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at 1 Year: An Open-Label, Non-Randomized, Controlled Study

(2018) Sarah J. Hallberg et al.   Diabetes Therapy

The Three-Factor Eating Questionnaire, body mass index, and responses to sweet and salty fatty foods: a twin study of genetic and environmental associations

(2018) Kaisu Keskitalo et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Effects of Liraglutide on Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus With or Without History of Myocardial Infarction or Stroke

(2018) Subodh Verma et al.   CIRCULATION

Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: an 18-month prospective study

(2016) Manfredi Rizzo et al.   Cardiovascular Diabetology

Once-Daily Liraglutide Versus Lixisenatide as Add-on to Metformin in Type 2 Diabetes: A 26-Week Randomized Controlled Clinical Trial

(2016) Michael Nauck et al.   DIABETES CARE

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

(2016) Steven P. Marso et al.   NEW ENGLAND JOURNAL OF MEDICINE

Liraglutide Reduces Oxidative Stress And Restores Heme Oxygenase-1 and Ghrelin Levels in Patients with Type 2 Diabetes: A Prospective Pilot Study

(2015) Manfredi Rizzo et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Sex Differences in the Impact of the Mediterranean Diet on LDL Particle Size Distribution and Oxidation

(2015) Alexandra Bédard et al.   Nutrients

Anti-atherosclerotic effects of the glucagon-like peptide-1 (GLP-1) based therapies in patients with type 2 Diabetes Mellitus: A meta-analysis

(2015) Xiaoyan Song et al.   Scientific Reports

Less but better: cardioprotective lipid profile of patients with GCK-MODY despite lower HDL cholesterol level

(2014) Wojciech Fendler et al.   ACTA DIABETOLOGICA

Liraglutide decreases carotid intima-media thickness in patients with type 2 diabetes: 8-month prospective pilot study

(2014) Manfredi Rizzo et al.   Cardiovascular Diabetology

Emerging therapies for raising high-density lipoprotein cholesterol (HDL-C) and augmenting HDL particle functionality

(2013) Marcin Barylski et al.   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: The SCALE Maintenance randomized study

(2013) T A Wadden et al.   INTERNATIONAL JOURNAL OF OBESITY

Lifestyle and Metformin Treatment Favorably Influence Lipoprotein Subfraction Distribution in the Diabetes Prevention Program

(2013) R. Goldberg et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Small, Dense LDL Particles Predict Changes in Intima Media Thickness and Insulin Resistance in Men with Type 2 Diabetes and Prediabetes – A Prospective Cohort Study

(2013) Philipp A. Gerber et al.   PLoS One

Pioglitazone and metformin are equally effective in reduction of chemerin in patients with type 2 diabetes

(2013) Alireza Esteghamati et al.   Journal of Diabetes Investigation

Editorial [ Reducing Cardiovascular Risk: Is Low-Density Lipoprotein-Cholesterol (LDL-C) Lowering Enough? ]

(2012) Michael S. Kostapanos et al.   Current Vascular Pharmacology

Short-term effects of liraglutide on visceral fat adiposity, appetite, and food preference: a pilot study of obese Japanese patients with type 2 diabetes

(2011) Kana Inoue et al.   Cardiovascular Diabetology

“European Panel on Low Density Lipoprotein (LDL) Subclasses”: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses

(2011) Dimitri P. Mikhailidis et al.   Current Vascular Pharmacology

Ethnic differences in serum lipoproteins and their determinants in South African women

(2010) Julia H. Goedecke et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Atherogenic lipoprotein phenotype and LDL size and subclasses in drug-naïve patients with early rheumatoid arthritis

(2009) Manfredi Rizzo et al.   ATHEROSCLEROSIS

Harmonizing the Metabolic Syndrome

(2009) K.G.M.M. Alberti et al.   CIRCULATION

Effects of 1-year treatment with metformin on metabolic and cardiovascular risk factors in non-diabetic upper-body obese subjects with mild glucose anomalies: A post-hoc analysis of the BIGPRO1 trial

(2009) A. Fontbonne et al.   DIABETES & METABOLISM

Atherogenic dyslipidemia and oxidative stress: a new look

(2009) Manfredi Rizzo et al.   Translational Research

Atherogenic lipoprotein phenotype and LDL size and subclasses in women with gestational diabetes

(2008) M. Rizzo et al.   DIABETIC MEDICINE